HighCape Capital Acquisition Corp. (CAPA) to Combine with Quantum-Si in $924M Deal
HighCape (NASDAQ:CAPA) has entered into a definitive agreement to combine with proteomics biotech firm Quantum-Si (QSi) for an enterprise value of $924.5 million, or 18.5x its 2023E revenue. QSi produces advanced spectrometers and software tools for analyzing and sequencing genomes and proteomes. The combined entity is expected to trade on the Nasdaq under the symbolRead More